Top Banner
Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero RL University of Texas Health Science Center-San Antonio VERDICT Health Services Research Program, South Texas Veterans Health Care System
19

Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Dec 13, 2015

Download

Documents

Aleesha Dorsey
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c

Parchman ML, Pugh JA, Romero RLUniversity of Texas Health Science Center-San Antonio

VERDICT Health Services Research Program, South Texas Veterans Health Care System

Page 2: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Background: Quality of Healthcare Health Plan & Providers Performance

Audit & feedback QI Improvement programs

Quality Indicators focus on delivery or receipt of a service, e.g. Immunization given Screening test performed Foot exam done

Feasibility/Data Availability: ease of administrative data access

Page 3: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Understanding Quality of Care High level

administrative data Health Plan Performance Clinic-level Performance Provider-level

Performance The “black box” of the

clinical encounter

Page 4: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Clinic-Level Performance: Process Measures Done, CVD Risks Good: A1c<7; BP<130/80; LDL-C< 100

0

10

20

30

40

50

60

70

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Clinic

%All 6 done

All 3 good

Page 5: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Objective: Inside the “Black Box” To examine the relationship between

performance of technical/process measures of quality of care inside the primary care encounter and medication intensification for poorly controlled diabetes

Is the likelihood that a change in medication occurred among patients with an elevated A1c associated with process measure performance?

Page 6: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Methods: Sample

20 diverse primary care clinics across South Texas 12 unaffiliated with 1-2 physicians 2 single specialty groups with 3 or more physicians 2 VA clinics 1 Federal Qualified Community Health Center 3 city/county clinics

~10 consecutive patients with T2DM in each clinic

Page 7: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Methods: Data Collection

Trained Observer: Direct observation of encounter

Patient Exit Survey Chart review

Most recent A1c value Number of medications Indicated diabetes service done in past year

Page 8: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Direct Observation of Encounter Length of visit (minutes) Change in a hypoglycemic medication

(yes/no) Number of topics and issues raised by the

patient or the physician Number of indicated diabetes services done

Page 9: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Indicated Diabetes Services

If not done in past year by chart review Foot exam Referral for eye exam A1c ordered Lipid panel ordered Urine micro-albumin ordered BP measured

For analysis converted to “all indicated done: yes/no”

Page 10: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Analysis

Dependent: change in medication Independent: all indicated services done

(yes/no) Co-variates

Length of visit Number of topics/issues raised by patient or physician, Most recent A1c level Number of chronic medications.

Page 11: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Results 195 patients encounters observed

98 (55.4%) had an A1c above 7.0 and the analysis was limited to this group

35(35.6%) had a change in medication. All indicated diabetes services done in 36 (37%)

of encounters Visit Length, minutes (mean 16.8, SD 7.8)

Less than 10: 22.3% 10 to 19: 40.4% 20 or more: 37.2%

Page 12: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Number Indicated and % Done

100 100

42.9 43.8 43.3

16.7

0

20

40

60

80

100

120

1 2 3 4 5 6

# Indicated services

% of visits all done

Page 13: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

All Indicated Services Done?

41.4

7.1

45.8

60

29.4

16.7 15.4

46.7

0

10

20

30

40

50

60

70

All Visits < 10 min 10 to 19 >=20

Minutes

% change meds

No

Yes

Page 14: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Final Model (n=98)

OR (95% CI)

All Done 0.24 (0.08, 0.78)

Length of visit 1.11 (1.01, 1.21)

# patient questions 0.57 (0.38, 0.84)

MD topics 1.03 (.91, 1.16)

Recent A1c level 1.20 (.89, 1.62)

# Medications 1.26 (1.05, 1.51)

Page 15: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Discussion

In visits where all DM indicated services were performed, patients were less likely to have a change in hypoglycemic medication if A1c > 7%

High levels of competing demands: 16.7 minute visits 17.7 issues/topics/questions by pt and MD

Unintended consequences?

Page 16: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Performance Measurement

Performance measures for quality of care often driven by available data

Settle for measures that are simple and easy to gauge? Is the “good” the enemy of the “best.”

Assumption: if we measure it, outcomes will improve Measurement necessary but not sufficient

Page 17: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Conclusions

“HEDIS-style performance measures…represent inefficient and sometimes counter-productive standards for improving clinical outcomes.” Hayward RA, NEJM 2007

Page 18: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Discussion

Studies of strategies to “un-burden” the demands on primary care clinicians during patient encounters are needed Panel Size? Pharmacists led-clinics Group clinics Caution on adding additional demands on patients

for additional trips and visits and co-pays Patient-Centered Goal: prevent diabetes

complications by controlling A1c, BP, lipids

Page 19: Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Acknowledgements

The research reported here was supported by: Agency for Healthcare Research and Quality (K08

HS013008-02), Kay Anderson, Project Officer Department of Veterans Affairs, Veterans Health

Administration, Health Services Research and Development Service. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.

Members, South Texas Ambulatory Research Network (STARNet)

Contact: [email protected]